📰 Forward Looking Statement News
Page 34 - Forward Looking Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forward Looking Statement. Real-time updates on events, politics, business and more.
July 10, 2022
Changes expected to have positive impact on 2023 earnings Company ending its participation in the BPCI-A program to focus on supporting future growth DALLAS & NEW YORK – July 8, 2022 – Signify Health, Inc.
July 6, 2022
Eastern Management Group Survey recognizes Sangoma as Number One in Customer Satisfaction for the third year.
June 30, 2022
29.06.2022 - OTTAWA, June 29, 2022 (GLOBE NEWSWIRE) - Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) is pleased to announce that all items of business presented for approval at its annual ...
June 23, 2022
Basel, June 21, 2022 — Today, Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a new, negative decision regarding the validity of US Patent No.
June 23, 2022
In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young LLP as the Companys auditors and approving the unallocated shares, rights and other entitlements under the Companys share purchase plan.
June 22, 2022
Exhibit Follows Successful Roll-Out of Law Enforcement-Specific Product LineLAS VEGAS, NV / ACCESSWIRE / June 22, 2022 / Cytta Corp (OTCQB:CYCA), (the "Company") today announced that they will be a noted
June 15, 2022
The contracts include an enterprise emergency management services agreement with MetLife Stadium in East Rutherford, New Jersey.
June 14, 2022
DHI Group, Inc. (NYSE: DHX) ("DHI" or the "Company") today announced that it signed an amended and restated credit agreement increasing the size from a $90 million revolving credit facility to a $100 million revolving credit facility, with an accordion feature for an additional $50 million.
June 11, 2022
Data from 75 patients with transfusion-dependent beta thalassemia or severe sickle cell disease with follow-up of up to 37.2 months continue to demonstrate that exa-cel has the potential to be
June 11, 2022
– Data from 75 patients with transfusion-dependent beta thalassemia or severe sickle cell disease with follow-up of up to 37.2 months continue to demonstrate that exa-cel has the potential to be a one-time functional cure –– Safety profile generally consistent with myeloablative conditioning and autologous stem cell...